Miriam Wilmes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Miriam Wilmes has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Hans-Georg Sahl
Institute for Medical Microbiology, Immunology and Parasitology (IMMIP), Pharmaceutical Microbiology Unit, University of Bonn, D-53115 Bonn, Germany
2 shared publications - Andre J. Ouellette
Department of Pathology and Laboratory Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA
1 shared publication - Dat Q. Tran
Department of Pathology and Laboratory Medicine, USC Norris Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089-9601, USA
1 shared publication - Dina Raafat
Institute of Immunology, University Medicine Greifswald, Greifswald, Germany
1 shared publication - Friedrich Götz
Microbial Genetics, Institute of Microbiology and Infection Medicine Tübingen, University of Tübingen, 72076 Tübingen, Germany
1 shared publication - Gabriele Bierbaum
Institute of Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany
1 shared publication
Latest Publications
- 1 February 2017
- Published by Elsevier in Carbohydrate Polymers
- Vol. 157, 146-155
Development of in vitro resistance to chitosan is related to changes in cell envelope structure of Staphylococcus aureus
- 1 February 2017
- Published by Elsevier in Carbohydrate Polymers
- Vol. 157, 146-155
Development of in vitro resistance to chitosan is related to changes in cell envelope structure of Staphylococcus aureus
- 22 November 2016
- Published by Springer Nature
- Vol. 1520, 133-143
Determination of Bacterial Membrane Impairment by Antimicrobial Agents
The bacterial cytoplasmic membrane separates the cell from its environment and acts as a selective permeability barrier. In addition, it functions in energy conservation, transport, and biosynthesis processes. Antimicrobial agents disrupting these functions may lead to pleiotropic effects, including leakage of low molecular weight compounds such as ions, amino acids and ATP, and subsequent membrane depolarization. This article describes two techniques to assess antibiotic-induced membrane impairment in vivo.
- 22 November 2016
- Published by Springer Nature
- Vol. 1520, 133-143
Determination of Bacterial Membrane Impairment by Antimicrobial Agents
The bacterial cytoplasmic membrane separates the cell from its environment and acts as a selective permeability barrier. In addition, it functions in energy conservation, transport, and biosynthesis processes. Antimicrobial agents disrupting these functions may lead to pleiotropic effects, including leakage of low molecular weight compounds such as ions, amino acids and ATP, and subsequent membrane depolarization. This article describes two techniques to assess antibiotic-induced membrane impairment in vivo.
- Open Access
- 14 November 2014
- Published by MDPI AG in Antibiotics
- Vol. 3 (4) , 617-631
Killing of Staphylococci by θ-Defensins Involves Membrane Impairment and Activation of Autolytic Enzymes
θ-Defensins are cyclic antimicrobial peptides expressed in leukocytes of Old world monkeys. To get insight into their antibacterial mode of action, we studied the activity of RTDs (rhesus macaque θ-defensins) against staphylococci. We found that in contrast to other defensins, RTDs do not interfere with peptidoglycan biosynthesis, but rather induce bacterial lysis in staphylococci by interaction with the bacterial membrane and/or release of cell wall lytic enzymes. Potassium efflux experiments and membrane potential measurements revealed that the membrane impairment by RTDs strongly depends on the energization of the membrane. In addition, RTD treatment caused the release of Atl-derived cell wall lytic enzymes probably by interaction with membrane-bound lipoteichoic acid. Thus, the premature and uncontrolled activity of these enzymes contributes strongly to the overall killing by θ-defensins. Interestingly, a similar mode of action has been described for Pep5, an antimicrobial peptide of bacterial origin.
- 14 November 2014
- Published by MDPI AG in Antibiotics
- Vol. 3 (4) , 617-631
Open AccessKilling of Staphylococci by θ-Defensins Involves Membrane Impairment and Activation of Autolytic Enzymes
θ-Defensins are cyclic antimicrobial peptides expressed in leukocytes of Old world monkeys. To get insight into their antibacterial mode of action, we studied the activity of RTDs (rhesus macaque θ-defensins) against staphylococci. We found that in contrast to other defensins, RTDs do not interfere with peptidoglycan biosynthesis, but rather induce bacterial lysis in staphylococci by interaction with the bacterial membrane and/or release of cell wall lytic enzymes. Potassium efflux experiments and membrane potential measurements revealed that the membrane impairment by RTDs strongly depends on the energization of the membrane. In addition, RTD treatment caused the release of Atl-derived cell wall lytic enzymes probably by interaction with membrane-bound lipoteichoic acid. Thus, the premature and uncontrolled activity of these enzymes contributes strongly to the overall killing by θ-defensins. Interestingly, a similar mode of action has been described for Pep5, an antimicrobial peptide of bacterial origin.